Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

INTEGRAL AD SCIENCE HOLDING CORP. Director's Dealing 2024

Jul 8, 2024

31817_dirs_2024-07-08_df1e29af-0409-4f97-b27c-a9a8b17d1bc0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INTEGRAL AD SCIENCE HOLDING CORP. (IAS)
CIK: 0001842718
Period of Report: 2024-07-03

Reporting Person: Utzschneider Lisa (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2024-07-03 Common Stock, $0.001 par value M 17869 Acquired 221008 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-07-03 Market Stock Units $ M 17869 Disposed Common Stock, $0.001 par value (17869) Direct

Footnotes

F1: Represents shares of common stock earned upon the vesting of market stock units granted on April 3, 2023.

F2: The number of market stock units reported represents the maximum possible number of shares that are eligible for vesting, which is 225% of the number of shares that would be earned at target. The minimum payout factor that must be achieved to earn any payout is 60%. The actual number of shares that will vest on each vesting date will be determined by comparing the price of common stock on the applicable vesting date to the price of common stock on April 3, 2023 (i.e., number of vested shares is equal to (i) the number of shares at target payout multiplied by (ii) (a) the average price of common stock for the 10 trading days immediately preceding the applicable vesting date divided by (b) the closing stock price on April 3, 2023).

F3: The market stock units vest 25% on April 3, 2024 and in equal installments every three months thereafter over a three year period, subject to continued employment.